¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"neoplasm, residual"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® neoplasm ÇÑ±Û ½Å»ý¹°
¼³¸í   
  »õ·Î »ý±ä ¹°ÁúÀ̶ó´Â ¶æÀÌ´Ù. À̰ÍÀº ´Ù¸¥ ¸»·Î ¡°Á¾¾ç(tumor)¡±À̶ó°íµµ Çϴ µ¥, ½ÇÁ¦·Î À̵éÀÇ ¸íÈ®ÇÑ ¶æÀº ¼­·Î ´Ù¸£´Ù. Á¾¾çÀ̶ó´Â ¸»Àº ¡°±× Å©±â°¡ 1cm°¡ ³Ñ´Â ÀÏÁ¾ÀǠȤ¡±À» ¸»Çϴ °ÍÀ¸·Î ÇǺΰú¿¡¼­´Â À̺¸´Ù ÀÛÀº È¤À» ±¸ÁøÀ̶ó°í ÇÏ¿© ±¸º°ÇÏ¿© ºÎ¸¥´Ù. ÇÏÁö¸¸, À̰ÍÀº ¶ÇÇÑ ÇǺλӸ¸ ¾Æ´Ï¶ó ½Åü³» ¾îµð¿¡¼­µç »ý±æ ¼ö ÀÖÀ¸¹Ç·Î ¸ðµÎ ÅëĪÇÏ¿© Á¾¾çÀ̶ó°í ºÎ¸¥´Ù. ÀÌ¿¡ ºñÇØ ¡°½Å»ý¹°¡±Àº ½Åü³» ¾ø´ø °ÍÀÌ »õ·Î »ý°Ü³µ´Ù´Â ¶æÀ¸·Î ºÙÀΠ¸»ÀÌ´Ù. ±×·¯³ª, ÀÌ µÑÀÇ °ü°è¸¦ ¸íÈ®È÷ ±ÔÁ¤ÁþÁö ¾Ê°í ÀÖÀ¸¸ç ´ë°³ °°Àº ¶æÀ¸·Î È¥¿ëµÈ´Ù.
  
  ½Å»ý¹°¿¡´Â ¡°¾ç¼º(benign)¡±°ú ¡°¾Ç¼º(malignant)¡±ÀÌ ÀÖ´Ù. ÀÌ µÑÀÇ ±¸º°Àº ¿©·¯ °¡Áö ±âÁØ¿¡ µû¸£Áö¸¸, ¶§·Î´Â ±¸º°ÀÌ ¾î·Á¿ï ¶§µµ ÀÖ´Ù. ´ë°³ ¾ç¼ºÀº »ý¸í´ÜÃàÀ» Àß ÀÏÀ¸Å°Áö ¾Ê´Â °ÍÀ¸·Î Ä¡·áÈÄ¿¡ Àç¹ßµµ Àß ÇÏÁö ¾Ê´Â´Ù. ÀÌ¿¡ ºñÇØ ¾Ç¼ºÀº Àç¹ß»Ó¸¸ ¾Æ´Ï¶ó ´Ù¸¥ ±â°üÀ¸·Î ¿Å°Ü°¡¼­ °°Àº º´º¯ÀÌ ¹ß»ýÇϴ ¡°ÀüÀÌ(metastasis)¡±Çö»óµµ ÀϾ´Ù. µû¶ó¼­ »ý¸íÀ» ´ÜÃà½Ã۴ °æ¿ì°¡ ¸¹À¸¸ç, ´ë°³ Ä¡·á°¡ ¾î·Æ´Ù.
¿µ¹® residual urine ÇÑ±Û ÀÜ´¢
¼³¸í   
  ¿ÀÁÜÀ» ´©°í ³­ µÚ¿¡µµ ¹æ±¤ ¼Ó¿¡ ³²´Â ¿ÀÁÜ. ¹æ±¤¿¡ ±â´É Àå¾Ö°¡ Àְųª ¹æ±¤¸ñ¿¡ º´ÀÌ ÀÖÀ» ¶§ ³ªÅ¸³­´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • benign neoplasm
    ¾ç¼ºÁ¾¾ç
  • cutaneous neoplasm
    ÇǺÎÁ¾¾ç
  • cystic neoplasm
    ³¶¼º½Å»ý¹°, ³¶¼ºÁ¾¾ç
  • neoplasm
    ½Å»ý¹°, Á¾¾ç
  • functional residual air
    ±â´ÉÀûÀܱâ
  • functional residual capacity
    ±â´ÉÀܱâ¿ë·®
  • residual
    1. ÀÜ·ù- 2. ÀÜ¿©-, ÀÜÁ¸- 3. ÈÄÀ¯-
  • residual abscess
    ÀÜ·ù°í¸§Áý, ÀÜ·ù³ó¾ç
  • residual accommodation
    ÀÜ¿©Á¶Àý
  • residual antigen
    ÀÜ·ùÇ׿ø
  • residual astigmatism
    ÀÜÁ¸³­½Ã
  • residual chlorine
    ÀÜ·ù¿°¼Ò
  • residual chromatin
    ÀÜ¿©¿°»öÁú
  • residual current
    ÀÜ·ùÀü·ù
  • residual cyst
    ÀÜ·ù³¶
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neoplasm
    ½Å»ý¹°, Á¾¾ç
  • cystic neoplasm
    ³¶Á¾
  • functional residual capacity
    ±â´ÉÀܱâ¿ë·®
  • residual period
    ÀÜ·ù±â°£
  • residual urine
    ÀÜ´¢
  • residual volume
    Àܱⷮ, ³²Àº°ø±â·®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • borderline malignant epithelial ovarian neoplasm
    °æ°è¾Ç¼º»óÇdz­¼ÒÁ¾¾ç
  • cutaneous neoplasm
    ÇǺÎÁ¾¾ç
  • neoplasm
    ½Å»ý¹°, Á¾¾ç
  • functional residual air
    ±â´ÉÀûÀܱâ
  • residual abscess
    ÀÜ·ù°í¸§Áý, ÀÜ·ù³ó¾ç
  • residual accommodation
    ÀÜ¿©Á¶Àý
  • residual antigen
    ÀÜ¿©Ç׿ø
  • residual astigmatism
    ÀÜ¿©³­½Ã
  • coherent residual transverse magnetization
    °áÁýÀÜ·ù°¡·ÎÃàÀÚ±âÈ­
  • functional residual capacity
    ±â´ÉÀûÀܱâ¿ë·®
  • residual carbon
    ÀÜ¿©Åº¼Ò
  • residual chlorine
    ÀÜ·ù¿°¼Ò
  • residual chromatin
    ÀÜ¿©¿°»öÁú
  • residual current
    ÀÜ·ùÀü·ù
  • residual cyst
    ÀÜ·ù³¶
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hepatic neoplasm
    °£½Å»ý¹°(ÊÜãæßæÚª).
  • RV=£¾residual volume
    Àü±â·®.
  • free available chlorine residual
    À¯¸®ÀÜ·ù ¿°¼Ò.
  • functional residual air =FRA
    ±â´É(Àû) Àܱâ(¡­íÑѨ).
  • functional residual capacity =FRC
    ±â´ÉÀû ÀÜ·ù¿ë·®(íÑ×¶éÄÕá), ±â´ÉÀû Àܱⷮ(íÑѨÕá).
  • hearing, residual
    ÀÜû
  • rate of residual expansion
    ÀÜÁ¸ÆØÃ¢·ü(íÑðíø³óìëÒ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cutaneous neoplasm
    ÇǺνŻý¹°, ÇǺÎÁ¾¾ç(¡­ðþåË).
  • cutaneous neoplasm
    ÇǺνŻý¹°, ÇǺÎÁ¾¾ç(¡­ðþåË)
  • hepatic neoplasm
    °£½Å»ý¹°(ÊÜãæßæÚª).
  • lymphoplasmacytic neoplasm
    ¸²ÇÁÇüÁú¼¼Æ÷¼º ½Å»ý¹°
  • malignant neoplasm
    ¾Ç¼º½Å»ý¹°(¡­ãæßæÚª).
  • malignant neoplasm
    ¾Ç¼º½Å»ý¹°(¡­ãæßæÚª)
  • neoplasm =neoplasma
    ½Å»ý¹° Á¾¾ç(¡­ðþåË)
  • organoid neoplasm
    ±â°ü¾ç½Å»ý¹°(ÐïίåÆãæßæÚª)
  • testis neoplasm
    °íȯ½Å»ý¹°(ÍÂü¯ãæßæÚª).
  • testis neoplasm
    °íȯ½Å»ý¹°(ÍÂü¯ãæßæÚª)
  • thyroid neoplasm
    °©»ó¼±½Å»ý¹°(¡­ãæßæÚª)
  • coherent residual transverse magnetization
    °áÁý ÀÜ·ù ȾÃà ÀÚ±âÈ­
  • combined available chlorine residual
    °áÇÕÀÜ·ù¿°¼Ò(˭̰ËöËôËçËÛ).
  • cyst, residual
    ÀÜ·ù³¶
  • free available chlorine residual
    À¯¸®ÀÜ·ù ¿°¼Ò.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Residual spindle
    ¹æÃßÀ¯¹°
    [¿¾ ¿ë¾î] ¹æÃßÀÜ¿©
  • Residual chromatin
    ¿°»öÁúÀÜ¿© [È£¿°±â¼º°ú¸³]
    [¿¾ ¿ë¾î] ¿°»öÁúÀÜ¿©
  • Residual lumen
    ÀÜ¿©³»°­
    [¿¾ ¿ë¾î] ÀÜ¿©°­
  • Residual body
    ÀÜ¿©¼Òü
    [¿¾ ¿ë¾î] ÀÜ¿©¼Òü
  • Residual body
    ÀÜ¿©¼Òü
    [¿¾ ¿ë¾î] ÀÜÀ¯¼Òü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • residual body
    ÀÜ·ùü
  • residual period
    ÀÜ·ù±â°£
  • residual spray
    ÀÜ·ùºÐ¹«
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • residual air
    ÀÜ·ù °ø±â(íÑ׺ÍöѨ)
  • residual body
    ÀÜ¿© ¼Òü(íÑæ®á³ô÷)
  • residual index
    ÀÜ¿© Áö¼ö(ò¦â¦)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • malignant neoplasm
    ¾Ç¼º½Å»ý¹°
  • neoplasm
    ½Å»ý¹°
  • coherent residual transverse magnetization
    °áÁýÀÜ·ùȾÃàÀÚ±âÈ­
  • incoherent residual transverse magnetization
    ºñ°áÁýÀÜ·ùȾ´ÜÀÚ±âÈ­
  • residual
    ÀÜ·ùÀÇ, ÀÜ¿©ÀÇ
  • residual transverse magnetization
    ÀÜ¿©È¾ÀÚ±â
  • residual urine
    ÀÜ´¢
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CEA Carcino-Embryonic Antigen [HP 1825-6]
  ; Oncofetal Antigens
  ; Glycopro...
CBN cannabinol; central benign neoplasm; Commission on Biological Nomenclature
FMN first malignant neoplasm; flavin mononucleotide; frontomaxillonasal [suture]
GENPS genital neoplasm-papilloma syndrome
MRN malignant renal neoplasm
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SMN Second Malignant Neoplasm
FRC Functional Residual Capacity
VmaxFRC Maximal flow at functional residual capacity
MRD Minimal Residual Disease
RV Residual Volume
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • disseminated malignant neoplasm
    ÆÛÁ® ÀÖ´Â ¾Ï
  • hematologic neoplasm
    Ç÷¾× ½Å»ý¹°
  • immunologic neoplasm
    ¸é¿ªÇÐÀû ½Å»ý¹°, ¸é¿ªÇÐÀû Á¾¾ç
  • malignant neoplasm
    ¾Ç¼º ½Å»ý¹°
  • functional residual capacity
    ±â´ÉÀû ÀÜ·ù ¿ë·®, ±â´ÉÀû Àܱⷮ
  • incoherent residual transverse magnetization
    ºñ°áÁý ÀÜ·ù Ⱦ´Ü ÀÚ±âÈ­
  • residual
    ÀÜ·ù, ÀÜÁ¸, ÀÜ»çÀÇ, ÀÜ·ùÇü, ÀÜ·ùÀÇ, ÀÜ¿©ÀÇ
    ÀÜ·ùÇϰųª µÚ¿¡ ³²Àº.
  • residual body
    ÀÜ¿©Ã¼
    Plasmodium¿¡¼­¿Í °°ÀÌ »ý½Ä ºÐ¿­À» ¿Ï·áÇÑ ÈÄ ³²¾ÆÀÖ´Â ¿øÇüÁú µ¢¾î¸®.
  • residual bone
    ÀÜÁ¸°ñ
  • residual cyst
    ÀÜ·ù ³¶, ÀÜ·ù¼º ³­Á¾
    1. ´ë°³ Ä¡±Ù´Ü ³¶Á¾À¸·Î ÇØ´ç Ä¡¾ÆÀÇ ¹ßÄ¡ ÈÄ¿¡µµ ±× ÀÚ¸®¿¡ ³²¾Æ¼­ ¹ß»ýÇÑ´Ù. ¹æ»ç¼± »çÁø»ó º´¼Ò´Â °æ°è°¡ ¸íÈ®ÇÑ ±ÕÁúÇÑ ´Ü¹æ¼º ¾Ï¿°À» ³ªÅ¸³½´Ù. 2. ´ë°³ Ä¡±Ù´Ü ³¶Á¾À¸·Î ÇØ´ç Ä¡¾ÆÀÇ ¹ß°Å ÈÄ¿¡µµ ±× À§Ä¡¿¡ ³²¾Æ¼­ ¹ß»ýÇÑ´Ù. ÀÜ·ù¼º, Ãø¹æ Ä¡ÁÖ¼º ¹× ÇÔÄ¡¼º ³¶Á¾ µîÀº »óÈ£ ºñ½ÁÇÏ¿© °¨º°ÀÌ Èûµé ¶§°¡ Àֱ⠶§¹®¿¡ ¹ßÄ¡Àü ¹æ»ç¼± »çÁøÀ» Âü°íÇØ¾ß ÇÏ¸ç ¾Ç°ñÀÇ ¹«Ä¡¾Ç ºÎÀ§¿¡ ¹ß»ýÇÏ´Â ¿ø½Ã¼º ³¶Á¾µµ ¼úÀü ±â·Ï°ú º´·ÂÀ¸·Î °¨º°ÇÑ´Ù. ¹æ»ç¼± »çÁø»ó, º´¼Ò´Â °æ°è°¡ ¸íÈ®ÇÑ ±ÕÁúÇÑ ´Ü¹æ¼º ¾Ï¿µÀ» ³ªÅ¸³½´Ù. ¿Í°úÀû ÀýÃâ°ú ¼ÒÆÄ¼ú·Î Ä¡·áÇÑ´Ù.
  • residual dental caries
    ÀÜÁ¸ Ä¡¾Æ¿ì½ÄÁõ
    ÀÜÁ¸ Ä¡¾Æ ¿ì½Ä »ó¾ÆÁú. ¿ì½ÄÀÌ µÈ ¹°ÁúÀÌ »èÁ¦µÈ ¿Íµ¿¿¡ ³²¾Æ ÀÖ°í ±× À§¿¡ ÃæÀü¹°ÀÌ À§Ä¡ÇÑ °Í.
  • residual mercury
    ÀÜ¿© ¼öÀº
  • residual pulp
    Àܼö
  • residual ridge crest
    ÀÜÁ¸ Ä¡Á¶´É
  • residual root
    ÀܱÙ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
neoplasm, residual Remnant of a tumour or cancer after primary, potentially curative therapy. (dr. Daniel masys, written communication)
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
antibodies, neoplasm Immunoglobulins induced by antigens specific for tumours other than the normally occurring histocompatibility antigens.
(12 Dec 1998)
antigens, neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumour cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin.
(12 Dec 1998)
brain neoplasm Neoplasms of the part of the central nervous system contained within the cranium.
(12 Dec 1998)
genes, structural, neoplasm DNA sequences that code for RNA and for the proteins required for the enzymatic and structural function of neoplastic cells.
(12 Dec 1998)
mucinous cystic neoplasm of pancreas <radiology> = macrocystic adenoma of pancreas, cystadenoma / cystadenocarcinoma, M:F = 1:9, 40-60 years of age, malignant or pre-malignant, large mass (mean 12 cm), multilocular cysts, thick septations, tail / body in 85% (unlike adenocarcinoma and microcystic adenoma), hypo-/avascular, Differential diagnosis: panc pseudocyst, ** Cf: microcystic adenoma
(12 Dec 1998)
histoid neoplasm Old term for a neoplasm characterised by a cytohistologic pattern that closely resembles the tissue from which the neoplastic cells are derived.
(05 Mar 2000)
neoplasm <oncology, pathology> New and abnormal growth of tissue, which may be benign or cancerous.
(16 Dec 1997)
neoplasm circulating cells Exfoliate neoplastic cells circulating in the blood and associated with metastasizing tumours.
(12 Dec 1998)
neoplasm: gallium imaging <radiology> Useful: Hodgkin disease and histiocytic form of NHL poor sensitivity below the diaphragm, Burkitt lymphoma: almost 100% sensitivity, hepatoma: 90% sensitivity, melanoma: 90% sensitivity, leukaemia possibly useful: NHL: good for large and mediastinal lesions, nodal metastases from seminoma and embryonal cell carcinoma: 87% sensitivity, non-small cell lung CA: 85% sensitive not useful: head and neck, GI (especially adenocarcinoma), breast, gynaecological, kiddie tumours see: gallium: indications
(12 Dec 1998)
neoplasm invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue.
(12 Dec 1998)
neoplasm metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. The ability to metastasize is characteristic of all malignant neoplasms.
(12 Dec 1998)
neoplasm recurrence, local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.
(12 Dec 1998)
neoplasm regression, spontaneous Disappearance of a neoplasm or neoplastic state without the intervention of therapy.
(12 Dec 1998)
neoplasm seeding The local implantation of tumour cells by contamination of instruments and surgical equipment during and after surgical resection, resulting in local growth of the cells and tumour formation.
(12 Dec 1998)
neoplasm staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Neoplasm, Residual - »õâ Remnant of a tumor or cancer after primary, potentially curative therapy. (Dr. Daniel Masys, written communication)
    Synonyms : Minimal Disease, Residual, Residual Disease, Minimal, Residual Neoplasm, Cancer, Residual, Cancers, Residual, Disease, Minimal Residual, Disease, Residual Minimal, Diseases, Minimal Residual, Diseases, Residual Minimal, Minimal Diseases, Residual
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neoplasm
    (º´¸®)ü³»¿¡ »ý±â´Â ½Å»ý¹°;(ƯÈ÷)Á¾¾ç
  • residual
    ³ª¸ÓÁöÀÇ
  • residual
    ³²Àº;ÀÜ¿©ÀÇ;³ª¸ÓÁöÀÇ;À׿©ÀÇ;(°è»êÀÇÂø¿À°¡)¼³¸íµÇÁö ¾ÊÀº;ÀÜ¿© Àç»êÀÇ;ÀÜ¿©;³²Àº °Í;³ª¸ÓÁö;À׿©;¿ÀÂ÷;(¿µÈ­.TVÀÇ Àç¹æ¿µ.±¤°í ¹æ¼Ûµî¿¡¼­ Ã⿬ÀÚ¿¡°Ô ÁöºÒÇÏ´Â)Àç¹æ¼Û·á;~ly
  • residual error
    ¼³¸íµÇÁö ¾ÊÀº ¿ÀÂ÷ ]
  • residual insecticide
    ÀÜ·ù¼º »ìÃæÁ¦
  • residual oil
    ÀÜÀ¯(¿øÀ¯¸¦ Á¤Á¦ÇÑ ÈÄ¿¡ ³²Àº ¿ÀÀÏ)
  • residual power
    Á¤ºÎÀÇ ÀÜ¿© ±ÇÇÑ
  • residual product
    ÀÜ¿© »ý»ê¹°;ºÎ»ê¹°
  • residual property
    ÀÜ¿© Àç»ê
  • residual radiation
    ÀÜ·ù¹æ»ç¼±
  • residual ray
    ÀÜ·ù¼±
  • residual security
    ÀÜ¿© Áõ±Ç(º¸Åë ÁÖ³ª Àüȯ »çä)
  • residual sovereignty
    ÀáÀç ÁÖ±Ç
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á